← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Lifecell Corporation
Somerville, NJ
$6,081,964
Total funding
8
Grants
Funding over time
peak $1.7M · FY2008–14$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
DOD$3,398,178 · 3
NIH$2,683,786 · 5
By mechanism
—$3,398,178 · 3
R44$1,201,129 · 1
R01$1,184,295 · 1
R43$298,362 · 3
Investigators at Lifecell Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
ACELLULAR HUMAN TISSUE MATRIX RESEARCH$1,701,178
· FY2008 · Department of Defense
MATRIX-MEDIATED REGENERATION OF ORTHOPEDIC TISSUES FOR MILITARY APPLICATIONS$1,697,000
· FY2009 · Department of the Army
Biglycan as a Therapeutic for Muscular Dystrophy$552,091
R44 · FY2003 · NS
Biglycan as a Therapeutic for Muscular Dystrophy$548,725
R44 · FY2004 · NS
DECORIN AND BIGLYCAN: STRUCTURE AND FUNCTION$236,880
R01 · FY2003 · AR
DECORIN AND BIGLYCAN: STRUCTURE AND FUNCTION$236,880
R01 · FY2001 · AR
DECORIN AND BIGLYCAN: STRUCTURE AND FUNCTION$236,880
R01 · FY2002 · AR
DECORIN AND BIGLYCAN: STRUCTURE AND FUNCTION$236,880
R01 · FY2004 · AR
DECORIN AND BIGLYCAN: STRUCTURE AND FUNCTION$236,775
R01 · FY2000 · AR
Biglycan as a Therapeutic for Muscular Dystrophy$100,313
R44 · FY2002 · NS
Gene Activated Cymetra for Repair of Orthopaedic Tissue$100,312
R43 · FY2003 · AR
PRECLINICAL TRIAL OF DECORIN IN FIBROTIC DISEASE$100,000
R43 · FY2000 · DK
Biochemical Stabilization for Freeze Dried Platelets$98,050
R43 · FY2003 · HL
STRATTICE DERMAL MATRIX RESEARCH$0
· FY2014 · Department of Defense